The antioxidant defense protein heme oxygenase 1 is a novel target for statins in endothelial cells

This publication has 45 references indexed in Scilit:

• Aspirin Protects Endothelial Cells From Oxidant Damage Via the Nitric Oxide-cGMP Pathway
  Arteriosclerosis, Thrombosis, and Vascular Biology, 2003
• Absence of heme oxygenase‐1 exacerbates atherosclerotic lesion formation and vascular remodeling
  The FASEB Journal, 2003
• Statins as novel immunomodulators: From cell to potential clinical benefit
  Thrombosis and Haemostasis, 2003
• Microsatellite polymorphism in promoter of heme oxygenase-1 gene is associated with susceptibility to coronary artery disease in type 2 diabetic patients
  Human Genetics, 2002
• Fluvastatin suppresses oxidative stress and fibrosis in the interstitium of mouse kidneys with unilateral ureteral obstruction
  Kidney International, 2001
• Atorvastatin Upregulates Type III Nitric Oxide Synthase in Thrombocytes, Decreases Platelet Activation, and Protects From Cerebral Ischemia in Normocholesterolemic Mice
  Stroke, 2000
• Statins and Risk of Coronary Heart Disease
  Published by American Medical Association (AMA) ,2000
• Suppression of the reactive oxygen intermediates production of human macrophages by colorectal adenocarcinoma cell lines
  Immunology, 1999
• Inhibition of Protein Geranylgeranylation Causes a Superinduction of Nitric-oxide Synthase-2 by Interleukin-1β in Vascular Smooth Muscle Cells
  Published by Elsevier ,1997
• Higher Serum Bilirubin Is Associated With Decreased Risk for Early Familial Coronary Artery Disease
  Arteriosclerosis, Thrombosis, and Vascular Biology, 1996